chr3-12748730-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_018306.4(TMEM40):c.136G>A(p.Glu46Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00027 in 1,614,124 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_018306.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM40 | NM_018306.4 | c.136G>A | p.Glu46Lys | missense_variant | 3/12 | ENST00000314124.12 | NP_060776.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM40 | ENST00000314124.12 | c.136G>A | p.Glu46Lys | missense_variant | 3/12 | 2 | NM_018306.4 | ENSP00000322837.7 | ||
TMEM40 | ENST00000435218.6 | c.136G>A | p.Glu46Lys | missense_variant | 3/11 | 1 | ENSP00000405740.2 | |||
TMEM40 | ENST00000264728.8 | c.136G>A | p.Glu46Lys | missense_variant | 3/12 | 2 | ENSP00000264728.8 | |||
TMEM40 | ENST00000435575.5 | c.73+1030G>A | intron_variant | 2 | ENSP00000396895.1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000100 AC: 25AN: 249042Hom.: 0 AF XY: 0.0000816 AC XY: 11AN XY: 134816
GnomAD4 exome AF: 0.000278 AC: 406AN: 1461852Hom.: 0 Cov.: 32 AF XY: 0.000250 AC XY: 182AN XY: 727234
GnomAD4 genome AF: 0.000197 AC: 30AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74446
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at